In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
1 week 4 hours ago
5 weeks 14 hours ago
6 weeks 1 day ago
6 weeks 1 day ago
27 weeks 1 day ago
31 weeks 2 days ago
32 weeks 6 days ago
33 weeks 14 hours ago
45 weeks 2 days ago
51 weeks 18 hours ago